Fractyl Health (GUTS) reported new six-month data from its open-label REVEAL-1 cohort, showing that people with obesity who stopped GLP-1 drugs maintained both weight and glycemic control after a single Revita procedure.
The company said the results highlight Revita's potential as a first-in-class option for patients who need an alternative to long-term GLP-1 therapy.
Participants had previously lost an average of 24% of body weight on GLP-1 medication. Six months after discontinuation, those treated with Revita showed only a 1.5% average weight change and nearly flat HbA1c levels, contrasting sharply with published data showing meaningful weight regain and glycemic deterioration after GLP-1 withdrawal alone.
The metabolic profile remained steady across one, three, and six months, with no serious procedure-related adverse events and only mild, transient side effects reported. Procedure performance was also consistent, mirroring global real-world use.
Clinicians involved in the study said the durability is striking given that most patients typically regain weight within weeks of stopping GLP-1 therapy. Fractyl added that the findings support Revita's FDA Breakthrough Device designation and strengthen confidence ahead of multiple 2026 clinical milestones, including randomized data from the ongoing REMAIN-1 program and a potential PMA filing later in the year.
REVEAL-1 includes 22 treated participants, with six-month efficacy data available for 17, most of whom are women around age 50 with prior long-term GLP-1 exposure.
GUTS currently trades at $1.485 or 4.8034% lower on the NasdaqGM.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.